Clinical Trial Update: Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating hyperthermic intraperitoneal treatment with rmhTNF for colorectal cancer with peritoneal metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Peritoneal Metastases

Drugs mentioned

• rmhTNF (recombinant human tumor necrosis factor (rmhTNF))

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Peritoneal Metastases, Colorectal Cancer | Phase 2 | Status: UNKNOWN